Task: Answer the multiple-choice question.
Question: Which drug exhibits a -4.958\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COc1cc2nc(N3CCN(C(=O)[C@H]4COc5ccccc5O4)CC3)nc(N)c2cc1OC
b: Cc1ccccc1-n1c(C)nnc1SCc1cc(=O)oc2ccc3ccccc3c12
Answer: b. Cc1ccccc1-n1c(C)nnc1SCc1cc(=O)oc2ccc3ccccc3c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1-n1c(C)nnc1SCc1cc(=O)oc2ccc3ccccc3c12
Cc1ccccc1-n1c(C)nnc1SCc1cc(=O)oc2ccc3ccccc3c12
1-[[5-methyl-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]benzo[f]chromen-3-one